Inventor · disambiguated record
Victor Ling
Also filed as: LING VICTOR
5 granted patents·4 pending applications·107 citations·filing 1986–2020
79Inventor score
Files withQING BILE THERAPEUTICS INC3ACTIVE PASS PHARMACEUTICALS IN2ONTARIO CANCER INST2LING VICTOR1WANG RENXUE1
Top patents by PatentIndex Score
9 records- 0188US9295677B2Polyhydroxylated bile acids for treatment of biliary disordersLING VICTOR·Filed 2012·Granted Mar 29, 2016·62 cites·18 claims
- 0272US4837306AMethod for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigenONTARIO CANCER INST·Filed 1986·Granted Jun 6, 1989·39 cites·6 claims
- 0347US2020078374A1Polyhydroxylated bile acids for treatment of biliary disordersQING BILE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0443US6830913B1ABCB9 transporter and uses thereofACTIVE PASS PHARMACEUTICALS IN·Filed 2000·Granted Dec 14, 2004·1 cites·15 claims
- 0542US2011263546A1Polyhydroxylated Bile Acids for Treatment of Biliary DisordersWANG RENXUE·Filed 2009·Application pending·0 cites
- 0641US10543220B2Polyhydroxylated bile acids for treatment of biliary disordersQING BILE THERAPEUTICS INC·Filed 2015·Granted Jan 28, 2020·0 cites·12 claims
- 0739US2022227804A1Combination of a polyhydroxylated bile acid and a farnesoid x receptor agonistQING BILE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0838US2004235102A1Novel ABCB9 transporter and uses thereofACTIVE PASS PHARMACEUTICALS IN·Filed 2004·Application pending·0 cites
- 0932US5223400AImmunoassay method for determining the specificity of binding of a monoclonal antibody to an antigenONTARIO CANCER INST·Filed 1989·Granted Jun 29, 1993·5 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Victor Ling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →